drugset / Trial / NCT05752175
Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection
RandomizedParallel-groupDouble-blindTreatment
Summary
A randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of WPV01 in patients with mild/moderate COVID-19 infection
Timeline
- Start
- 2023-03-10
- Primary completion
- 2023-05-09
- Completion
- 2023-07-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WPV01 | Unknown | — | — |